Hosted on MSN

Eli Lilly Launches Mounjaro KwikPen in India; Is It Better Than Taking a Jab to Battle Diabetes and Obesity?

Eli Lilly has launched Mounjaro KwikPen, a trizetrapib for those battling type 2 diabetes and obesity, in India. According to the pharmaceutical giant, this multi-dose, single-patient-use, prefilled ...
Business Insider

Eli Lilly: Expanding Market Reach with KwikPen for Zepbound – A Buy Rating Review

In a report released today, Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $700.00. Mohit Bansal’s Buy rating for Eli Lilly & ...